Nazalong spray is appointed for treatment of sharp rhinitis (cold) of any origin: infectious, virus, vasomotorial or allergic (pollinosis). In complex treatment of sinusitis, an eustachitis, average otitis.

for the purpose of simplification of carrying out a rinoskopiya and surgical manipulations in a nasal cavity.

Structure

active ingredient: to oxymetazoline a hydrochloride of 100 g of medicine excipients contain to hydrochloride oxymetazoline in terms of 100% substance of 0.05 g

: a benzalkoniya chloride, polyethyleneglycol, Trilonum B, propylene glycol, povidone, sodium phosphate dodecahydrate, potassium dihydrophosphate, water purified.

Nazalong of ^® treats to group of local vasoconstrictors (dekongensantiv). Oxymetazoline the hydrochloride is a synthetic adrenomimetik and renders alpha adrenomimeticheskoye action.

Contraindication

Hypersensitivity to medicine components.

Atrophic rhinitis.

At use of MAO (MAO) inhibitors and within 2 weeks after the treatment termination by MAO inhibitors and also other medicines promoting increase in arterial blood pressure.

At raised intraocular pressure, especially at closed-angle glaucoma.

At severe forms of cardiovascular diseases (for example coronary heart disease, arterial hypertension).

Profound atherosclerosis, violation of a warm rhythm (for example tachycardia).

Pheochromocytomas.

Metabolic violations (hyperthyroidism, thyrotoxicosis, diabetes, porphyria).

prostate Hypertrophy.

Feature of application

Use during pregnancy or feeding by a breast

exceeding the recommended doses. During pregnancy and feeding by a breast medicament should be used with care only after careful assessment of a ratio of risk / advantage for mother and the fruit / child.

Children

children should not use Drug up to 6 years.

Ability to influence speed of response at control of motor transport or other mechanisms

After prolonged use of medicine in the doses exceeding recommended cannot exclude the general influence on cardiovascular and nervous system. In such cases the ability to steer the vehicle can decrease.

Route of administration and doses

1. To remove a protective cap. Before the first use of medicine several times to press the spray before emergence of a disperse stream.

2. To enter the spray into the nasal course and to make injection, having pressed against the stop the spray index and average fingers.

3. To make the necessary number of injections (see below) in each nasal course; at the same time there is no need to shower the head back.

4. During injection it is recommended to inhale easily through a nose that will promote optimum distribution of aerosol in a nasal cavity.

5. After use to close the spray a protective cap.

Adult on 1-2 injections, to children 6 years are more senior - on 1 injection in each nostril. The interval between applications of medicine has to make not less than 10-12 hours. A course of treatment - no more than 3-5 days.

Overdose

After considerable overdose or accidental intake such symptoms can arise: a mydriasis, nausea, vomiting, cyanosis, temperature increase, spasms, tachycardia, palpitation, arrhythmia, cardiovascular insufficiency, cardiac arrest, collapse, the increased sweating, excitement, spasms, arterial hypertension, a fluid lungs, respiratory frustration, pallor, a miosis, a hyposmia, mental disorders.

besides, excitement or oppression of functions from the central nervous system can arise, it is shown by drowsiness, decrease in body temperature, bradycardia, arterial hypotension, an apnoea and possible development of a coma.

Therapeutic actions at overdose: gastric lavage, intake of activated carbon, ventilation of the lungs. In a lowering of arterial pressure to apply phentolamine. It is not necessary to accept angiotonic means. If necessary therapy is shown anticonvulsant.

Side reactions

At frequent and prolonged use can arise burning sensation, prickings in a nose, inflows, sneezing, xeromycteria and/or a mouth or a throat. After the effect of use of medicine ends - feeling of strong congestion of a nose (reactive hyperemia). Prolonged continuous use of vasoconstrictive medicines can lead to a tachyphylaxis or development of medicamentous rhinitis. An apnoea at newborns and children of younger age (especially in case of overdose).

from a cardiovascular system. Tachycardia, palpitation (heartbeat), increase in arterial blood pressure, heartache.

from organs of sight. Irritation, discomfort or reddening of eyes.

from digestive tract. Nausea.

from the immune system. Emergence of allergic reactions and reaction of hypersensitivity, including rash, an itch, a Quincke's disease (Quincke's edema) is possible.

from a respiratory system. Discomfort or irritation in a nose, a mouth and a throat and also nasal bleedings.

from nervous system. Concern, hyperexcitability, a sleep disorder, insomnia, drowsiness, increased fatigue, a headache, spasms, hallucinations (especially at children).

Interaction with other medicines and other types of interactions

At co-administration of medicine with other vasoconstrictors (irrespective of a method of administration) perhaps mutual strengthening of side effects. Slows down absorption of mestnoanesteziruyushchy means and prolongs their effect. Strengthens effect of MAO inhibitors on the central nervous system. Because of risk of increase in arterial blood pressure it is not necessary to apply the MAO inhibitors, tricyclic antidepressants and other medicines promoting increase in arterial blood pressure together with ^{Nazalong medicine ®} .

to Store

in original packing at a temperature not above 25 °C. To store out of children's reach.

Expiration date - 2 years.